当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Sepsis researchers set sights on immunotherapeutic strategies
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-05-30 , DOI: 10.1038/nrd.2018.87 Asher Mullard
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-05-30 , DOI: 10.1038/nrd.2018.87 Asher Mullard
Sepsis researchers set sights on immunotherapeutic strategies
中文翻译:
脓毒症研究人员着眼于免疫治疗策略
脓毒症研究人员着眼于免疫治疗策略
更新日期:2018-05-31
Sepsis researchers set sights on immunotherapeutic strategies, Published online: 30 May 2018; doi:10.1038/nrd.2018.87
Two immune-boosting strategies have independently indicated promise in sepsis clinical trials, after years of failures with anti-inflammatories in this same space. Will it be enough to take sepsis drug development out of 'critical condition'?中文翻译:
脓毒症研究人员着眼于免疫治疗策略
脓毒症研究人员着眼于免疫治疗策略
脓毒症研究人员着眼于免疫治疗策略,在线发表于:2018年5月30日; doi:10.1038 / nrd.2018.87
在相同空间中抗炎药治疗失败多年后,有两种免疫增强策略已在脓毒症临床试验中独立表明了前景。将脓毒症药物开发排除在“危急状态”之外就足够了吗?